Invesco Nasdaq Biotechnology ETF (IBBQ)
NASDAQ: IBBQ · Real-Time Price · USD
22.06
-0.20 (-0.90%)
Mar 13, 2025, 4:00 PM EST - Market closed
IBBQ Holdings List
As of Mar 12, 2025
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | GILD | Gilead Sciences, Inc. | 10.33% |
2 | AMGN | Amgen Inc. | 9.27% |
3 | VRTX | Vertex Pharmaceuticals Incorporated | 8.88% |
4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.22% |
5 | AZN | AstraZeneca PLC | 4.27% |
6 | ALNY | Alnylam Pharmaceuticals, Inc. | 3.03% |
7 | BIIB | Biogen Inc. | 1.98% |
8 | ARGX | argenx SE | 1.85% |
9 | SNY | Sanofi | 1.68% |
10 | SMMT | Summit Therapeutics Inc. | 1.42% |
11 | RPRX | Royalty Pharma plc | 1.41% |
12 | ITCI | Intra-Cellular Therapies, Inc. | 1.35% |
13 | UTHR | United Therapeutics Corporation | 1.33% |
14 | MRNA | Moderna, Inc. | 1.30% |
15 | BMRN | BioMarin Pharmaceutical Inc. | 1.30% |
16 | ILMN | Illumina, Inc. | 1.29% |
17 | INSM | Insmed Incorporated | 1.28% |
18 | INCY | Incyte Corporation | 1.26% |
19 | ONC | BeiGene, Ltd. | 1.07% |
20 | NBIX | Neurocrine Biosciences, Inc. | 1.07% |
21 | VTRS | Viatris Inc. | 1.07% |
22 | EXEL | Exelixis, Inc. | 1.03% |
23 | MEDP | Medpace Holdings, Inc. | 0.98% |
24 | BNTX | BioNTech SE | 0.95% |
25 | SRPT | Sarepta Therapeutics, Inc. | 0.92% |
26 | PCVX | Vaxcyte, Inc. | 0.88% |
27 | ASND | Ascendis Pharma A/S | 0.88% |
28 | JAZZ | Jazz Pharmaceuticals plc | 0.79% |
29 | HALO | Halozyme Therapeutics, Inc. | 0.75% |
30 | ROIV | Roivant Sciences Ltd. | 0.75% |
31 | MDGL | Madrigal Pharmaceuticals, Inc. | 0.69% |
32 | TEM | Tempus AI, Inc. | 0.67% |
33 | RVMD | Revolution Medicines, Inc. | 0.64% |
34 | BBIO | BridgeBio Pharma, Inc. | 0.60% |
35 | AXSM | Axsome Therapeutics, Inc. | 0.56% |
36 | BPMC | Blueprint Medicines Corporation | 0.56% |
37 | ALKS | Alkermes plc | 0.52% |
38 | GH | Guardant Health, Inc. | 0.52% |
39 | IONS | Ionis Pharmaceuticals, Inc. | 0.51% |
40 | CYTK | Cytokinetics, Incorporated | 0.50% |
41 | KRYS | Krystal Biotech, Inc. | 0.50% |
42 | VRNA | Verona Pharma plc | 0.48% |
43 | NUVL | Nuvalent, Inc. | 0.46% |
44 | ADMA | ADMA Biologics, Inc. | 0.42% |
45 | PTCT | PTC Therapeutics, Inc. | 0.40% |
46 | ACLX | Arcellx, Inc. | 0.38% |
47 | RNA | Avidity Biosciences, Inc. | 0.38% |
48 | SWTX | SpringWorks Therapeutics, Inc. | 0.37% |
49 | RARE | Ultragenyx Pharmaceutical Inc. | 0.36% |
50 | CRSP | CRISPR Therapeutics AG | 0.36% |
51 | PTGX | Protagonist Therapeutics, Inc. | 0.33% |
52 | MRUS | Merus N.V. | 0.33% |
53 | SRRK | Scholar Rock Holding Corporation | 0.32% |
54 | CRNX | Crinetics Pharmaceuticals, Inc. | 0.32% |
55 | AKRO | Akero Therapeutics, Inc. | 0.31% |
56 | RYTM | Rhythm Pharmaceuticals, Inc. | 0.31% |
57 | APLS | Apellis Pharmaceuticals, Inc. | 0.30% |
58 | LEGN | Legend Biotech Corporation | 0.30% |
59 | ALVO | Alvotech | 0.29% |
60 | IMVT | Immunovant, Inc. | 0.27% |
61 | ACAD | ACADIA Pharmaceuticals Inc. | 0.27% |
62 | AMRX | Amneal Pharmaceuticals, Inc. | 0.27% |
63 | XENE | Xenon Pharmaceuticals Inc. | 0.26% |
64 | FOLD | Amicus Therapeutics, Inc. | 0.26% |
65 | VCYT | Veracyte, Inc. | 0.23% |
66 | EWTX | Edgewise Therapeutics, Inc. | 0.23% |
67 | RXRX | Recursion Pharmaceuticals, Inc. | 0.23% |
68 | TWST | Twist Bioscience Corporation | 0.23% |
69 | DNLI | Denali Therapeutics Inc. | 0.22% |
70 | KYMR | Kymera Therapeutics, Inc. | 0.22% |
71 | BEAM | Beam Therapeutics Inc. | 0.22% |
72 | VCEL | Vericel Corporation | 0.22% |
73 | NVCR | NovoCure Limited | 0.22% |
74 | NAMS | NewAmsterdam Pharma Company N.V. | 0.21% |
75 | MIRM | Mirum Pharmaceuticals, Inc. | 0.21% |
76 | LGND | Ligand Pharmaceuticals Incorporated | 0.20% |
77 | IBRX | ImmunityBio, Inc. | 0.19% |
78 | ARWR | Arrowhead Pharmaceuticals, Inc. | 0.19% |
79 | HRMY | Harmony Biosciences Holdings, Inc. | 0.19% |
80 | ZLAB | Zai Lab Limited | 0.18% |
81 | AGIO | Agios Pharmaceuticals, Inc. | 0.18% |
82 | DVAX | Dynavax Technologies Corporation | 0.17% |
83 | CGON | CG Oncology, Inc. | 0.17% |
84 | TARS | Tarsus Pharmaceuticals, Inc. | 0.17% |
85 | VERA | Vera Therapeutics, Inc. | 0.17% |
86 | ARQT | Arcutis Biotherapeutics, Inc. | 0.17% |
87 | APGE | Apogee Therapeutics, Inc. | 0.17% |
88 | SUPN | Supernus Pharmaceuticals, Inc. | 0.17% |
89 | TVTX | Travere Therapeutics, Inc. | 0.16% |
90 | JANX | Janux Therapeutics, Inc. | 0.16% |
91 | WVE | Wave Life Sciences Ltd. | 0.16% |
92 | IDYA | IDEAYA Biosciences, Inc. | 0.16% |
93 | IRON | Disc Medicine, Inc. | 0.15% |
94 | BCRX | BioCryst Pharmaceuticals, Inc. | 0.15% |
95 | CNTA | Centessa Pharmaceuticals plc | 0.15% |
96 | MNKD | MannKind Corporation | 0.14% |
97 | ANIP | ANI Pharmaceuticals, Inc. | 0.13% |
98 | LON: INDV | Indivior PLC | 0.13% |
99 | OCUL | Ocular Therapeutix, Inc. | 0.13% |
100 | NVAX | Novavax, Inc. | 0.13% |
101 | ARDX | Ardelyx, Inc. | 0.12% |
102 | GPCR | Structure Therapeutics Inc. | 0.12% |
103 | AMPH | Amphastar Pharmaceuticals, Inc. | 0.12% |
104 | DYN | Dyne Therapeutics, Inc. | 0.12% |
105 | SPRY | ARS Pharmaceuticals, Inc. | 0.12% |
106 | AUPH | Aurinia Pharmaceuticals Inc. | 0.11% |
107 | IOVA | Iovance Biotherapeutics, Inc. | 0.11% |
108 | TXG | 10x Genomics, Inc. | 0.11% |
109 | IMCR | Immunocore Holdings plc | 0.11% |
110 | ADPT | Adaptive Biotechnologies Corporation | 0.11% |
111 | SNDX | Syndax Pharmaceuticals, Inc. | 0.11% |
112 | SYRE | Spyre Therapeutics, Inc. | 0.11% |
113 | INVA | Innoviva, Inc. | 0.11% |
114 | GERN | Geron Corporation | 0.10% |
115 | GRAL | GRAIL, Inc. | 0.10% |
116 | ELVN | Enliven Therapeutics, Inc. | 0.10% |
117 | NRIX | Nurix Therapeutics, Inc. | 0.10% |
118 | PCRX | Pacira BioSciences, Inc. | 0.10% |
119 | VIR | Vir Biotechnology, Inc. | 0.10% |
120 | NTLA | Intellia Therapeutics, Inc. | 0.09% |
121 | ETNB | 89bio, Inc. | 0.09% |
122 | COLL | Collegium Pharmaceutical, Inc. | 0.09% |
123 | REPL | Replimune Group, Inc. | 0.09% |
124 | GRFS | Grifols, S.A. | 0.09% |
125 | XNCR | Xencor, Inc. | 0.09% |
126 | KNSA | Kiniksa Pharmaceuticals International, plc | 0.09% |
127 | AGPXX | Short-Term Investment Trust - Invesco Government & Agency Portfolio | 0.09% |
128 | FTRE | Fortrea Holdings Inc. | 0.09% |
129 | DAWN | Day One Biopharmaceuticals, Inc. | 0.09% |
130 | EOLS | Evolus, Inc. | 0.08% |
131 | ZYME | Zymeworks Inc. | 0.08% |
132 | GMAB | Genmab A/S | 0.08% |
133 | COGT | Cogent Biosciences, Inc. | 0.08% |
134 | HROW | Harrow, Inc. | 0.08% |
135 | RCKT | Rocket Pharmaceuticals, Inc. | 0.08% |
136 | AVDL | Avadel Pharmaceuticals plc | 0.07% |
137 | AVBP | ArriVent BioPharma, Inc. | 0.07% |
138 | AVXL | Anavex Life Sciences Corp. | 0.07% |
139 | PRTA | Prothena Corporation plc | 0.07% |
140 | PRAX | Praxis Precision Medicines, Inc. | 0.07% |
141 | CVAC | CureVac N.V. | 0.07% |
142 | ABCL | AbCellera Biologics Inc. | 0.07% |
143 | XERS | Xeris Biopharma Holdings, Inc. | 0.07% |
144 | LENZ | LENZ Therapeutics, Inc. | 0.07% |
145 | CRMD | CorMedix Inc. | 0.06% |
146 | MLYS | Mineralys Therapeutics, Inc. | 0.06% |
147 | QURE | uniQure N.V. | 0.06% |
148 | SANA | Sana Biotechnology, Inc. | 0.06% |
149 | ARVN | Arvinas, Inc. | 0.06% |
150 | RLAY | Relay Therapeutics, Inc. | 0.06% |
151 | ABUS | Arbutus Biopharma Corporation | 0.06% |
152 | KURA | Kura Oncology, Inc. | 0.06% |
153 | KALV | KalVista Pharmaceuticals, Inc. | 0.06% |
154 | ORIC | ORIC Pharmaceuticals, Inc. | 0.05% |
155 | PGEN | Precigen, Inc. | 0.05% |
156 | CSTL | Castle Biosciences, Inc. | 0.05% |
157 | TYRA | Tyra Biosciences, Inc. | 0.05% |
158 | VERV | Verve Therapeutics, Inc. | 0.05% |
159 | ANAB | AnaptysBio, Inc. | 0.05% |
160 | CGEM | Cullinan Therapeutics, Inc. | 0.05% |
161 | MGTX | MeiraGTx Holdings plc | 0.05% |
162 | EYPT | EyePoint Pharmaceuticals, Inc. | 0.05% |
163 | KROS | Keros Therapeutics, Inc. | 0.05% |
164 | TRVI | Trevi Therapeutics, Inc. | 0.05% |
165 | HCM | HUTCHMED (China) Limited | 0.05% |
166 | BCYC | Bicycle Therapeutics plc | 0.05% |
167 | MNMD | Mind Medicine (MindMed) Inc. | 0.05% |
168 | TBPH | Theravance Biopharma, Inc. | 0.05% |
169 | OMER | Omeros Corporation | 0.04% |
170 | SAGE | Sage Therapeutics, Inc. | 0.04% |
171 | URGN | UroGen Pharma Ltd. | 0.04% |
172 | STOK | Stoke Therapeutics, Inc. | 0.04% |
173 | PAHC | Phibro Animal Health Corporation | 0.04% |
174 | RNAC | Cartesian Therapeutics, Inc. | 0.04% |
175 | SVRA | Savara Inc. | 0.04% |
176 | ERAS | Erasca, Inc. | 0.04% |
177 | ALLO | Allogene Therapeutics, Inc. | 0.04% |
178 | MESO | Mesoblast Limited | 0.04% |
179 | SIGA | SIGA Technologies, Inc. | 0.04% |
180 | ZVRA | Zevra Therapeutics, Inc. | 0.04% |
181 | TRDA | Entrada Therapeutics, Inc. | 0.04% |
182 | TRML | Tourmaline Bio, Inc. | 0.04% |
183 | GLUE | Monte Rosa Therapeutics, Inc. | 0.04% |
184 | ORKA | Oruka Therapeutics, Inc. | 0.04% |
185 | ATXS | Astria Therapeutics, Inc. | 0.04% |
186 | AUTL | Autolus Therapeutics plc | 0.04% |
187 | ALT | Altimmune, Inc. | 0.04% |
188 | HUMA | Humacyte, Inc. | 0.04% |
189 | OABI | OmniAb, Inc. | 0.04% |
190 | ARCT | Arcturus Therapeutics Holdings Inc. | 0.04% |
191 | AURA | Aura Biosciences, Inc. | 0.04% |
192 | GLPG | Galapagos NV | 0.04% |
193 | MRVI | Maravai LifeSciences Holdings, Inc. | 0.04% |
194 | RAPP | Rapport Therapeutics, Inc. | 0.04% |
195 | TECX | Tectonic Therapeutic, Inc. | 0.04% |
196 | RIGL | Rigel Pharmaceuticals, Inc. | 0.03% |
197 | ABSI | Absci Corporation | 0.03% |
198 | TSHA | Taysha Gene Therapies, Inc. | 0.03% |
199 | PACB | Pacific Biosciences of California, Inc. | 0.03% |
200 | PHAT | Phathom Pharmaceuticals, Inc. | 0.03% |
201 | MXCT | MaxCyte, Inc. | 0.03% |
202 | RGNX | REGENXBIO Inc. | 0.03% |
203 | TERN | Terns Pharmaceuticals, Inc. | 0.03% |
204 | VNDA | Vanda Pharmaceuticals Inc. | 0.03% |
205 | ITOS | iTeos Therapeutics, Inc. | 0.03% |
206 | ESPR | Esperion Therapeutics, Inc. | 0.03% |
207 | CRVS | Corvus Pharmaceuticals, Inc. | 0.03% |
208 | TKNO | Alpha Teknova, Inc. | 0.03% |
209 | AMLX | Amylyx Pharmaceuticals, Inc. | 0.03% |
210 | AVIR | Atea Pharmaceuticals, Inc. | 0.03% |
211 | ANNX | Annexon, Inc. | 0.03% |
212 | DSGN | Design Therapeutics, Inc. | 0.03% |
213 | SLRN | Acelyrin, Inc. | 0.03% |
214 | PSNL | Personalis, Inc. | 0.03% |
215 | AQST | Aquestive Therapeutics, Inc. | 0.03% |
216 | NGNE | Neurogene Inc. | 0.03% |
217 | OLMA | Olema Pharmaceuticals, Inc. | 0.02% |
218 | TSVT | 2seventy bio, Inc. | 0.02% |
219 | FHTX | Foghorn Therapeutics Inc. | 0.02% |
220 | ACIU | AC Immune SA | 0.02% |
221 | PRME | Prime Medicine, Inc. | 0.02% |
222 | IRWD | Ironwood Pharmaceuticals, Inc. | 0.02% |
223 | ALMS | Alumis Inc. | 0.02% |
224 | SLDB | Solid Biosciences Inc. | 0.02% |
225 | CDXS | Codexis, Inc. | 0.02% |
226 | NMRA | Neumora Therapeutics, Inc. | 0.02% |
227 | YMAB | Y-mAbs Therapeutics, Inc. | 0.02% |
228 | VYGR | Voyager Therapeutics, Inc. | 0.02% |
229 | INBX | Inhibrx Biosciences, Inc. | 0.02% |
230 | TNGX | Tango Therapeutics, Inc. | 0.02% |
231 | SLN | Silence Therapeutics plc | 0.02% |
232 | FDMT | 4D Molecular Therapeutics, Inc. | 0.02% |
233 | TVGN | Tevogen Bio Holdings Inc. | 0.02% |
234 | CRGX | CARGO Therapeutics, Inc. | 0.02% |
235 | CMPS | COMPASS Pathways plc | 0.02% |
236 | LYEL | Lyell Immunopharma, Inc. | 0.02% |
237 | AMRN | Amarin Corporation plc | 0.02% |
238 | LRMR | Larimar Therapeutics, Inc. | 0.02% |
239 | ACRV | Acrivon Therapeutics, Inc. | 0.02% |
240 | MGNX | MacroGenics, Inc. | 0.02% |
241 | ALEC | Alector, Inc. | 0.02% |
242 | THRD | Third Harmonic Bio, Inc. | 0.02% |
243 | ENTA | Enanta Pharmaceuticals, Inc. | 0.01% |
244 | CCCC | C4 Therapeutics, Inc. | 0.01% |
245 | LXRX | Lexicon Pharmaceuticals, Inc. | 0.01% |
246 | ARTV | Artiva Biotherapeutics, Inc. | 0.01% |
247 | SCPH | scPharmaceuticals Inc. | 0.01% |
248 | EDIT | Editas Medicine, Inc. | 0.01% |
249 | NKTX | Nkarta, Inc. | 0.01% |
250 | FATE | Fate Therapeutics, Inc. | 0.01% |
251 | STRO | Sutro Biopharma, Inc. | 0.01% |
252 | KYTX | Kyverna Therapeutics, Inc. | 0.01% |
253 | BMEA | Biomea Fusion, Inc. | 0.01% |
254 | LXEO | Lexeo Therapeutics, Inc. | 0.01% |
255 | PLRX | Pliant Therapeutics, Inc. | 0.01% |
256 | TCRX | TScan Therapeutics, Inc. | 0.01% |
257 | CLYM | Climb Bio, Inc. | 0.01% |
258 | PEPG | PepGen Inc. | 0.01% |
259 | INZY | Inozyme Pharma, Inc. | 0.01% |
260 | PYXS | Pyxis Oncology, Inc. | 0.01% |
261 | MRSN | Mersana Therapeutics, Inc. | 0.01% |
262 | OKUR | OnKure Therapeutics, Inc. | 0.01% |
263 | APLT | Applied Therapeutics, Inc. | 0.01% |
264 | IGMS | IGM Biosciences, Inc. | 0.00% |
265 | QTTB | Q32 Bio Inc. | 0.00% |
266 | n/a | Cartesian Therapeutics ([Wts/Rts]) 0% | 0.00% |
267 | n/a | Omniab | 0.00% |
268 | n/a | Omniab | 0.00% |
269 | n/a | Securities Lending - Bnym | 0.00% |
270 | n/a | Cash | -0.00% |
As of Mar 12, 2025